Noel Guzman
Family Medicine · Vancouver, WANPI 1780604413
Payments from drug & device makers
Across 468 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- Pfizer$898
- Amgen$730
- GSK$655
- Boehringer Ingelheim$599
- plus $4K from 32 others
What the payments were for
- Food & beverage$9,22899%
- Education$1221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 61 | $1,633 |
| AbbVie(2 entities) | 56 | $1,137 |
| Pfizer | 47 | $898 |
| Amgen | 31 | $730 |
| GSK | 36 | $655 |
| Boehringer Ingelheim | 34 | $599 |
| Lilly USA, LLC | 25 | $506 |
| Novo Nordisk | 26 | $483 |
| E.r. Squibb & Sons, L.L.C. | 22 | $379 |
| Johnson & Johnson | 15 | $315 |
| Sanofi-aventis U.S. LLC | 14 | $304 |
| Astellas Pharma US Inc | 12 | $193 |
| CMP Pharma, Inc. | 10 | $193 |
| Kowa Pharmaceuticals America, Inc. | 13 | $125 |
| Amarin Pharma, Inc. | 6 | $118 |
| Novartis | 6 | $108 |
| Merck | 7 | $93 |
| Bayer | 6 | $91 |
| Exact Sciences | 4 | $89 |
| Gilead | 4 | $86 |
| Abbott | 3 | $75 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $68 |
| Sanofi Pasteur Inc. | 3 | $60 |
| Medtronic | 1 | $56 |
| Bausch Health US, LLC | 2 | $47 |
| Boston Scientific | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 3 | $38 |
| Circassia Inc. | 2 | $32 |
| Radius Health, Inc. | 2 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Corcept Therapeutics | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$245
- TRELEGY ELLIPTA$109
- ELIQUIS$104
- JARDIANCE$104
- FARXIGA$102
How this compares
$9,351 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 17 | $25,716 |
| OzempicSemaglutide | 18 | $22,071 |
| EliquisApixaban | 12 | $13,705 |
| Atorvastatin Calcium | 116 | $1,292 |
| Levothyroxine Sodium | 66 | $1,017 |
| Rosuvastatin Calcium | 53 | $987 |
| Olmesartan Medoxomil | 31 | $753 |
| Metoprolol Succinate | 44 | $606 |
| Omeprazole | 33 | $597 |
| Losartan Potassium | 38 | $527 |
| Tamsulosin Hcl | 36 | $523 |
| Amlodipine Besylate | 47 | $447 |
| Gabapentin | 26 | $430 |
| Bupropion XlBupropion Hcl | 11 | $426 |
| Lisinopril | 39 | $404 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $599 | $25,71617 claims |
| Novo NordiskOzempic | $483 | $22,07118 claims |
| PfizerEliquis | $898 | $13,70512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Vancouver
- Rick JacksonVancouver$28K
- Bernard StupskiVancouver$17K
- Donald BenzVancouver$14K
- Anton GraschWenatchee$5.3M
- Gaylon KippBellevue$4.8M
- Steven KasterWenatchee$4M
- Angela EakinSpokane$3M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
- Brad FrandsenPort Orchard$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.